Clinicopathologic implication of A20/TNFAIP3 deletion in diffuse large B-cell lymphoma: an analysis according to immunohistochemical subgroups and rituximab treatment
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinicopathologic implication of A20/TNFAIP3 deletion in diffuse large B-cell lymphoma: an analysis according to immunohistochemical subgroups and rituximab treatment
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume 54, Issue 9, Pages 1934-1941
Publisher
Informa UK Limited
Online
2013-01-18
DOI
10.3109/10428194.2012.762511
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting A20 enhances TRAIL-induced apoptosis in hepatocellular carcinoma cells
- (2012) Bingfei Dong et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A novel A20 (TNFAIP3) antibody (Ber-A20) can be used to detect unmutated A20 by immunohistology
- (2012) Burkhard Hirsch et al. HISTOPATHOLOGY
- A20 Regulation of Nuclear Factor–κB
- (2011) Catriona Kelly et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma
- (2011) L. Giulino et al. BLOOD
- Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
- (2011) G. Gutierrez-Garcia et al. BLOOD
- A20, ABIN-1/2, and CARD11 Mutations and Their Prognostic Value in Gastrointestinal Diffuse Large B-Cell Lymphoma
- (2011) Gehong Dong et al. CLINICAL CANCER RESEARCH
- WHO Classification of Malignant Lymphomas in Korea: Report of the Third Nationwide Study
- (2011) Jin-Man Kim et al. Korean Journal of Pathology
- Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome
- (2011) F C M Braun et al. LEUKEMIA
- Prognostic impact of MUM1 expression by immunohistochemistry on primary mediastinal large B-cell lymphoma
- (2011) Celso A. L. De Mello et al. LEUKEMIA & LYMPHOMA
- Thymic extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a clinicopathological and genetic analysis of six cases
- (2011) Heounjeong Go et al. LEUKEMIA & LYMPHOMA
- A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis
- (2011) Mourad Matmati et al. NATURE GENETICS
- Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus
- (2011) Indra Adrianto et al. NATURE GENETICS
- A20 Modulates Lipid Metabolism and Energy Production to Promote Liver Regeneration
- (2011) Scott M. Damrauer et al. PLoS One
- A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies
- (2010) Nadine Hövelmeyer et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tumor Suppressor A20 Protects Against Cardiac Hypertrophy and Fibrosis by Blocking Transforming Growth Factor-β–Activated Kinase 1–Dependent Signaling
- (2010) He Huang et al. HYPERTENSION
- Targeting A20 Decreases Glioma Stem Cell Survival and Tumor Growth
- (2010) Anita B. Hjelmeland et al. PLOS BIOLOGY
- MUM1/IRF4
- (2010) Gabriela Gualco et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma
- (2009) W. Y. Kim et al. ANNALS OF ONCOLOGY
- TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas
- (2009) K. Honma et al. BLOOD
- A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy
- (2009) W. W.L. Choi et al. CLINICAL CANCER RESEARCH
- A20 is overexpressed in glioma cells and may serve as a potential therapeutic target
- (2009) Qingdong Guo et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- TNFAIP3(A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
- (2009) Roland Schmitz et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma
- (2009) E Chanudet et al. LEUKEMIA
- Frequent inactivation of A20 in B-cell lymphomas
- (2009) Motohiro Kato et al. NATURE
- MYCtranslocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type
- (2008) S O Yoon et al. HISTOPATHOLOGY
- TNFAIP3is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma
- (2007) Keiichiro Honma et al. GENES CHROMOSOMES & CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now